Skip to content

Sam's News β€” health β€” 2026-08-28

Health

7 Light-activated eye drops restore vision in blind mice

Scientists at IBEC developed light-activated small-molecule drugs delivered as eye drops that restored light perception and visually guided behavior in blind mice without gene therapy, implants, or specialized lighting. The compounds target photoreceptor degeneration from diseases like age-related macular degeneration and retinitis pigmentosa affecting approximately 200 million people worldwide.

  • Light-activated compounds restore vision without gene therapy or implants
  • Two most promising compounds administered as eye drops or eye injections
  • Target photoreceptor degeneration from AMD and retinitis pigmentosa
  • Affect ~200 million people with these diseases globally; do not cure underlying degeneration
  • Compounds show promising safety profiles

Sources: ScienceDaily AI Web Searched, ScienceDaily β€” Health RSS

6.5 Vanillin vape flavoring may disrupt early embryo development

Lab experiments show that vanillin, a common e-cigarette vanilla flavoring, can impair embryonic stem cells and interfere with normal early development.

Sources: ScienceDaily β€” Health RSS

6.5 AstraZeneca investigates failed heart disease drug trial with broader implications

AstraZeneca has detailed the unexpected failure of a closely watched heart disease trial with ramifications across the competitive billion-dollar market.

Sources: STAT News RSS

6 Study finds fungal toxins in all 212 plant-based meat alternatives tested

A UK study found that all 212 plant-based meat alternatives examined contained at least one naturally occurring fungal toxin, though levels remained below EU guideline limits.

Sources: ScienceDaily RSS, ScienceDaily β€” Health RSS, ScienceDaily β€” Nutrition RSS

6 AstraZeneca and Ionis report failure of heart disease drug candidate

AstraZeneca and Ionis have announced disappointing trial results for their heart disease drug, with implications for similar programs at competitors.

Sources: STAT News RSS

6 Cytokinetics reports trial success for potential second drug approval

After 27 years to achieve its first approval, Cytokinetics has reported positive results that could accelerate approval of its second drug.

Sources: STAT News RSS

Education

7 20-year study: public pre-K attendance linked to lasting academic gains through high school

A 20-year longitudinal study of 400,000 Miami-Dade County students found that attending public school pre-K4 significantly improved grades and test scores through high school compared to other childcare settings. The advantage persisted into adolescence and was attributed to better-trained teachers and earlier exposure to structured classroom routines.

  • 20-year study tracked 400,000 students in Miami-Dade County public schools
  • Public pre-K4 students had higher grades and test scores through high school
  • Academic advantages linked to college-educated teachers and structured classroom exposure
  • Study included largest Hispanic sample (~70% of cohort) in preschool research of its kind

Sources: ScienceDaily AI Web Searched, ScienceDaily β€” Health RSS

Pharmaceuticals

6.5 FDA approves Roivant's dermatomyositis therapy for rare autoimmune disease

The FDA approved a new Roivant/Priovant medicine for treating dermatomyositis, a rare autoimmune disease.

Sources: STAT News RSS

Research Integrity

5.5 Former Stanford president releases emails to refute fraud allegations in upcoming book

Marc Tessier-Lavigne published correspondence and research details in an attempt to counter fraud and cover-up accusations documented in a new book.

Sources: STAT News RSS

Policy

5.5 CMS to Launch Medicare Chronic Care Pilot Program ACCESS

The Centers for Medicare and Medicaid Services has scheduled a launch event for the ACCESS Medicare chronic care management pilot program.

Sources: STAT News RSS